Goldman Sachs Group Inc Becton Dickinson & CO Call Options Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$232.24 - $267.23 $6.36 Million - $7.32 Million	27,400 New	27,400 $6.68 Million
Q4 2022 May 14, 2024	BUY	$218.29 - $256.91 $38.2 Million - $44.9 Million	174,800 Added 197.51%	263,300 $67 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $38.2 Million - $44.9 Million	174,800 Added 197.51%	263,300 $67 Million
Q3 2022 May 14, 2024	BUY	$51.03 - $264.23 $4.27 Million - $22.1 Million	83,600 Added 1706.12%	88,500 $19.7 Million
Q3 2022 Nov 10, 2022	BUY	$51.03 - $264.23 $4.27 Million - $22.1 Million	83,600 Added 1706.12%	88,500 $19.7 Million
Q2 2022 May 14, 2024	SELL	$234.74 - $275.42 $5.28 Million - $6.2 Million	-22,500 Reduced 82.12%	4,900 $1.21 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $1.15 Million - $1.35 Million	4,900 New	4,900 $1.21 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.